QA: Ocata Therapeutics Inc in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001140098_2012_Ocata_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001140098, Ocata Therapeutics Inc

  xvar xval
0 AssetsCurrent 13,406,690
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 154,771
3 remainder_Assets 1,623,865
4 LiabilitiesCurrent 0
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 59,880,044
7 CostOfGoodsAndServicesSold 343,950
8 SellingGeneralAndAdministrativeExpense 11,025,459
9 ResearchAndDevelopmentExpense 10,021,863
10 remainder_Expenses 225,505
11 remainder_Revenues 506,419
12 remainder_NetIncome -51,684,761
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,185,326
1 Liabilities 59,880,044
2 Expenses 21,616,777
3 Revenues 506,419
4 StockholdersEquity -44,694,718
5 NetIncome -72,795,119
6 ComprehensiveNetIncome -72,795,119
7 BaseVar 74,436,664
8 EconomicCapitalRatiobeforeLimitedLiability -4.54
9 EconomicCapitalRatio 0.272

Edgar->Model Mapping

Feature Distribution